Diuretic and natriuretic responses in rats treated with enkephalinase inhibitors.
Rat atrial natriuretic factor (125I-rANF, 99-128) is hydrolysed by pure enkephalinase (EC 3.4.24.11) in vitro at a rate similar to that of 125I-hANF. Trichloroacetic precipitated radioactivity was significantly elevated in the kidneys of rats pretreated with acetorphan, an enkephalinase inhibitor, and receiving 125I-rANF, indicating that the exogenous hormone was protected against degradation. A single oral administration of acetorphan elicited diuretic and natriuretic effects in conscious normotensive rats and natriuretic effects in spontaneously hypertensive rats, effects which were not accompanied by significant changes in kaliuresis. The diuretic and natriuretic effects were still observed in conscious normotensive rats after three days of repeated administration of the drug. In conscious or anesthetized rats in which volume expansion was elicited by hydroelectrolytic loads, the initial rate of urinary elimination of water and sodium was nearly doubled by treatment with enkephalinase inhibitors. This effect was prevented by coadministration of an ANF antiserum, which suggests that the effect was mediated by endogenous ANF. These various observations suggest that enkephalinase inhibitors protect endogenous ANF from degradation and thereby enhance the typical renal effects of the hormone.
Bralet
J
J
Laboratoire de Pharmacodynamie, Faculté de Pharmacie de Dijon, France.
Mossiat
C
C
Lecomte
J M
JM
Charpentier
S
S
Gros
C
C
Schwartz
J C
JC
D000818:Animals; D009320:Atrial Natriuretic Factor / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism*; D002851:Chromatography, High Pressure Liquid; D004231:Diuresis / Q000187:drug effects*; D007275:Injections, Intravenous; D008297:Male; D009318:Natriuresis / Q000187:drug effects*; D015260:Neprilysin / Q000037:antagonists & inhibitors* / Q000097:blood; D011188:Potassium / Q000652:urine*; D011355:Prodrugs; D051381:Rats; D011918:Rats, Inbred SHR; D011919:Rats, Inbred Strains; D015244:Thiorphan / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000494:pharmacology*; D013997:Time Factors
D011355:Prodrugs; C049331:racecadotril; D009320:Atrial Natriuretic Factor; D015244:Thiorphan; D015260:Neprilysin; D011188:Potassium